antimony has been researched along with Adverse Drug Event in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cota, GF; de Sousa, MR; Fereguetti, TO; Rabello, A | 1 |
| Andrade, CA; Martins, MM; Marzochi, MC; Oliveira, LF; Oliveira, RV; Passos, SL; Schubach, AO | 1 |
| Alavi, I; Berman, J; Cruz, M; Gracia, L; Guzman, M; Maldonado, M; Nena, W; Rojas, E; Soto, J; Toledo, J; Verduguez, A; Villarroel, D | 1 |
| Hashem, N; Shawki, R | 1 |
2 review(s) available for antimony and Adverse Drug Event
| Article | Year |
|---|---|
Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antimony; Antiprotozoal Agents; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Survival Analysis; Treatment Outcome; Young Adult | 2013 |
Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Incidence; Leishmaniasis, Cutaneous; Pentamidine | 2011 |
1 trial(s) available for antimony and Adverse Drug Event
| Article | Year |
|---|---|
Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antimony; Antiprotozoal Agents; Bolivia; Child; Cryotherapy; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Middle Aged; Placebos; Treatment Outcome; Young Adult | 2013 |
1 other study(ies) available for antimony and Adverse Drug Event
| Article | Year |
|---|---|
Cultured peripheral lymphocytes: one biologic indicator of potential drug hazard.
Topics: Adolescent; Antimony; Antimony Potassium Tartrate; Child; Child, Preschool; Chromosomes, Human; Drug-Related Side Effects and Adverse Reactions; Epilepsy, Tonic-Clonic; Female; Humans; Isoniazid; Lymphocytes; Male; Mitosis; Niridazole; Peritonitis, Tuberculous; Phenytoin; Schistosomiasis; Tuberculosis, Pulmonary | 1976 |